. Thorax, 30,[158][159][160][161]. Tricuspid valve replacement: a five-year appraisal. Organic disease of the tricuspid valve required surgery in 18% of all patients undergoing valve replacement over a five-year period. Differentiation of organic from functional disease is difficult and may be made only at open-heart surgery. The results of a series of 56 patients who underwent tricuspid valve replacement are presented; of these, 53 had organic disease. Operative mortality at the end of five years had fallen to 7% with significant clinical improvement in 79% of patients, a reduction in cardiothoracic ratio in 81%, and a low incidence of postoperative tricuspid incompetence.
Clinical reports of patients with rheumatic heart disease suggest that 10-20% have organic tricuspid valve involvement (Sinclair-Smith, 1968; Braimbridge et al., 1970) . This is less than the prevalence rates of 22-44% found at necropsy (Kitchin and Turner, 1964) . The discrepancy between clinical and necropsy findings may be due to overshadowing features of mitral and aortic valve disease (Braimbridge et al., 1970) and to difficulty in differentiating organic from functional tricuspid incompetence on the basis of clinical, haemodynamic, and angiographic criteria.
According to Starr, Herr, and Wood (1966) , this failure in diagnosis of tricuspid valve disease may be as high as 30%. This has potentially serious consequences (Grondin et al., 1967; Pluth and Ellis, 1969) and accordingly the policy of routinely inspecting or palpating the tricuspid valve in all patients undergoing valve replacement surgery has been adopted whenever there has been any preoperative suspicion of tricuspid valve disease or if at operation the right atrium is enlarged. Subsequent criteria for replacement of the tricuspid valve depend on the degree of stenosis or incompetence noted at operation. This report concerns the results of a series of patients undergoing tricuspid valve replacement over a five-year period . ' Present address: Medical Division, The Victoria Infirmary, Glasgow,
G42 9TY PATIENTS AND METHODS
Fifty-six patients (nine male, 47 female) with a mean age of 44+8 years underwent tricuspid valve replacement under cardiopulmonary bypass. All patients had severe rheumatic valvular disease requiring reparative surgery of two or more valves (Table) . In the initial two years of the series Starr-Edwards prosthetic valves were used. Subsequently the Bjork-Shiley tilting disc prosthetic valve has been the choice for all valve replacements (Turner et al., 1974) .
Patients were classified by functional disability (New York Heart Association, Criteria Committee, 1964). Ninety-seven per cent were either grade 3 or 4 preoperatively in spite of full medical therapy, and only 3% were grade 2. All had rheumatic heart disease dominated by mitral and/or aortic valve disease.
Cardiomegaly was present in all patients, and radiological evidence of an enlarged right atrium in 75%, pleural effusion in 25%, and a prominent superior vena cava or azygos vein in 20%. Only seven patients were in sinus rhythm and the remaining 49 were in atrial fibrillation. Other electrocardiographic findings were related to the co-existent mitral and aortic valve disease. HAEMODYNAMIC AND OPERATIVE FINDINGS Preoperative cardiac catheterization was performed in 46 patients. Pulmonary hypertension was present in all (mean systolic pulmonary artery pressure 62±24 mmHg). As regards the tricuspid valve findings, five had evidence of pure tricuspid stenosis from right heart catheterization and this was confirmed when the valve was seen at operation.
Fifty-one patients had predominant tricuspid regurgitation with shortened distorted valve leaflets which also caused a degree of stenosis in nine patients. In 33 of these patients the classical features of severe tricuspid regurgitation, namely hepatic pulsation and a prominent V wave in the venous pulse with a systolic plateau wave form in the right atrial tracing, were detected. In the remainder these features were absent, inconstant or the subject of disagreement between observers although the valve was found to be regurgitant at operation. In nine patients a tricuspid lesion was totally unsuspected preoperatively on clinical or catheterization findings, being revealed at operation as a palpable thrill or progressive tricuspid incompetence as cardiopulmonary bypass was being discontinued.
Subsequent histological examination of the excised tricuspid valves revealed organic disease in all but three of the 56 cases. The three patients in whom the valve leaflets were regarded as normal had severe dilatation of the valve ring and co-existent pulmonary hypertension and were considered to have gross functional regurgitation. (three patients) but one patient had pulmonary thromboembolic disease and one an acute viral illness. Of the late deaths, one patient (Fig. 3,  patient A) , who developed cardiac failure with elevation of the mean right atrial pressure following double valve replacement, died during a second operation to repair a mitral prosthetic leak. At operation excess fibrin deposition was noted on the tricuspid prosthesis but this did not appear to interfere with its function.
RESULTS

Overall
Postoperative assessment of the tricuspid valve was made clinically in all patients and by right atrial catheterization in 14. A further patient (Fig. 3, patient B 
DISCUSSION
The variation in the frequency of tricuspid valve disease in rheumatic heart disease has been emphasized in previous studies. Thus 15-21% of patients at mitral valvotomy (Bailey and Bolton, 1956; Kitchin and Turner, 1964; Starr et al., 1966) or double valve replacement (Starr et al., 1966) have significant tricuspid pathology.
The current series of 56 patients represented 18% of all patients undergoing mitral and/or aortic valve replacement during the same fiveyear period.
The accurate differentiation of organic from functional incompetence can be difficult by clinical evaluation or even by catheterization and angiography, and attempts to quantify the degree of incompetence are unreliable (Cairns et al., 1968) . As a result, inspection and assessment at the time of operation become essential (Starr et al., 1966; Pluth and Ellis, 1969; Molloy and Clelland, 1972) .
The management of tricuspid regurgitation has been controversial, opinion being divided on the necessity for surgical treatment in organic as compared to functional regurgitation and between valvuloplasty and valve replacement as the operation of choice. High mortality and poor functional results in untreated series (Grondin et al., 1967) can be contrasted with that reported by Braunwald, Ross, and Morrow (1967) , who found that patients with tricuspid incompetence undergoing mitral valve replacement made slower postoperative progress but that eventually spontaneous regression of the tricuspid regurgitation occurred. Other workers (Pluth and Ellis, 1969; Starr et al., 1966) have not confirmed this spontaneous regression of tricuspid regurgitation though it may be that this is due to confusion in definition of organic and functional disease.
Experience in this centre is that many patients, in whom tricuspid valve replacement was considered at operation but not proceeded with, deteriorated in the postoperative period with progressive signs of tricuspid regurgitation. Three such patients required readmission for tricuspid valve replacement within 18 months of the first operation (a mitral valve replacement).
Overall it seems that organic regurgitation due to thickened, shortened, and adherent valve leaflets, and often accompanied by stenosis, should be treated by valve replacement. While some patients with mild to moderate functional regurgitation will regress with correction of mitral and/ or aortic valve dysfunction, there are those in whom functional regurgitation is gross and requires either a valve replacement or valvuloplasty (Pluth and Ellis, 1969; Starr, 1969) .
Much of the dramatic symptomatic and haemodynamic improvement in these patients is due to the operative correction of co-existent valve dysfunction but it is noted that the excellent functional result and the low incidence of postoperative tricuspid regurgitation recorded in this and other series of tricuspid valve replacement were not found in a comparable series when untreated or subjected to valvuloplasty by Pluth and Ellis (1969) .
An operative mortality of 25% has been recorded in previous series though Starr's achievement of 6% for combined mitral and tricuspid replacements is surprising when compared with the 15% mortality for pure mitral valve replacement. The extremely high operative mortality in the initial years of this study has progressively fallen annually to the acceptable level of 7% during the last year. There are several possible reasons for this but the most important seems likely to be the continuing improvement in surgical and postoperative techniques coupled with the use of a low-profile, low-inertia prosthesis. 
